Home
About
Overview
Sharing Data
ORCID
Help
History (4)
Antioxidant supplementation and risk of incident melanomas: results of a large prospective cohort study.
Gaps in epidemiologic research methods: design considerations for studies that use food-frequency questionnaires.
Impact of Chemotherapy Dosing on Ovarian Cancer Survival According to Body Mass Index.
Natural History of Multiple Recurrences in Intermediate-Risk Non-Muscle Invasive Bladder Cancer: Lessons From a Prospective Cohort.
See All 4 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Impact of Chemotherapy Dosing on Ovarian Cancer Survival According to Body Mass Index.
Impact of Chemotherapy Dosing on Ovarian Cancer Survival According to Body Mass Index. JAMA Oncol. 2015 Sep; 1(6):737-45.
View in:
PubMed
subject areas
Adult
Aged
Antineoplastic Combined Chemotherapy Protocols
Body Mass Index
California
Chemotherapy, Adjuvant
Chi-Square Distribution
Cisplatin
Drug Dosage Calculations
Health Maintenance Organizations
Humans
Logistic Models
Middle Aged
Multivariate Analysis
Neoplasms, Glandular and Epithelial
Obesity
Odds Ratio
Ovarian Neoplasms
Paclitaxel
Registries
Risk Assessment
Risk Factors
Time Factors
Treatment Outcome
Young Adult
authors with profiles
Lawrence H. Kushi, ScD